Roger Sidhu's most recent trade in Eterna Therapeutics Inc was a trade of 20,163 Common Stock done . Disclosure was reported to the exchange on Sept. 20, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Eterna Therapeutics Inc | Roger Sidhu | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Sep 2022 | 20,163 | 20,163 | - | - | Common Stock | |
| Eterna Therapeutics Inc | Roger Sidhu | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Sep 2022 | 20,163 | 60,487 | - | - | Restricted Stock Units | |
| Eterna Therapeutics Inc | Roger Sidhu | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2022 | 142,100 | 142,100 | - | - | Stock Option (Right to buy) | |
| Eterna Therapeutics Inc | Roger Sidhu | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Sep 2021 | 161,300 | 161,300 | - | - | Stock Option | |
| Eterna Therapeutics Inc | Roger Sidhu | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Sep 2021 | 80,650 | 80,650 | - | - | Restricted Stock Unit |